Security key
29772L108
Eton Pharmaceuticals, Inc. - Common Stock (ETON)
CUSIP: 29772L108
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 9,507,414
- Total 13F value
- $57,043,272
- Share change
- +1,276,640
- Put/Call ratio
- 0.19%
- SEC-reported price per share
- $6.00
- Number of holders
- 47
- Value change
- +$8,311,784
- Number of buys
- 23
- Number of sells
- 16
- Shares outstanding
- 27,281,304
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
47
Top holders
10
ETON full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Eton Pharmaceuticals, Inc. SEC filings
Eton Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29772L108
Recent filing periods:
Ownership snapshot
Top reported holders of ETON - Eton Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Opaleye Management Inc.
Disclosed value leader
Opaleye Management Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 8.8%
Showing 1-6 of 15 holder rows.
Quick read
Opaleye Management Inc. leads the comparable SEC ownership view at 8.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Opaleye Management Inc.'s linked filing trail.
Comparable ownership
Top 5
Opaleye Management Inc.
8.8%
VANGUARD GROUP INC
3.8%
Nantahala Capital Management, LLC
3.4%
Westside Investment Management, Inc.
2.1%
Acuitas Investments, LLC
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Opaleye Management Inc. |
13F
Company
|
8.8%
|
$7,879,550
2,395,000 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.8%
|
$3,381,093
1,027,688 shares
|
— | 30 Jun 2024 |
| Nantahala Capital Management, LLC |
13F
Company
|
3.4%
|
$3,095,012
940,733 shares
|
— | 30 Jun 2024 |
| Westside Investment Management, Inc. |
13F
Company
|
2.1%
|
$1,925,973
585,400 shares
|
— | 30 Jun 2024 |
| Acuitas Investments, LLC |
13F
Company
|
2.1%
|
$1,908,068
579,960 shares
|
— | 30 Jun 2024 |
| National Philanthropic Trust |
13F
Company
|
1.8%
|
$1,619,048
492,112 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
47
Shares
9,507,414
Rows available
47
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
44
Q3 2024 holders
47
Holder diff
3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend